Hiroki Kadota

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Metastatic Colorectal Cancer

Combination Therapy

Helicobacter Pylori

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Rina Otani, Hidehiko Takigawa, Ryo Yuge, Daisuke Shimizu, Misa Ariyoshi, Ryo Miyamoto, Hiroki Kadota, Yuichi Hiyama, Ryohei Hayashi, Yuji Urabe, Akira Ishikawa, Naohide Oue, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis. Cancers 15 (5) (2023)
Hidehiko Takigawa, Ryo Yuge, Ryo Miyamoto, Rina Otani, Hiroki Kadota, Yuichi Hiyama, Ryohei Hayashi, Yuji Urabe, Kazuhiro Sentani, Naohide Oue, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
Comprehensive Analysis of Gene Expression Profiling to Explore Predictive Markers for Eradication Therapy Efficacy against Helicobacter pylori -Negative Gastric MALT Lymphoma. Cancers 15 (4) (2023)
Rina Otani, Hidehiko Takigawa, Ryo Yuge, Daisuke Shimizu, Misa Ariyoshi, Ryo Miyamoto, Hiroki Kadota, Yuichi Hiyama, Ryohei Hayashi, Yuji Urabe, Akira Ishikawa, Naohide Oue, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis. Cancers 15 (5) (2023)
Hidehiko Takigawa, Ryo Yuge, Ryo Miyamoto, Rina Otani, Hiroki Kadota, Yuichi Hiyama, Ryohei Hayashi, Yuji Urabe, Kazuhiro Sentani, Naohide Oue, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
Comprehensive Analysis of Gene Expression Profiling to Explore Predictive Markers for Eradication Therapy Efficacy against Helicobacter pylori -Negative Gastric MALT Lymphoma. Cancers 15 (4) (2023)
Hidehiko Takigawa, Ryo Yuge, Ryo Miyamoto, Rina Otani, Hiroki Kadota, Yuichi Hiyama, Ryohei Hayashi, Yuji Urabe, Kazuhiro Sentani, Naohide Oue, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
Comprehensive Analysis of Gene Expression Profiling to Explore Predictive Markers for Eradication Therapy Efficacy against Helicobacter pylori -Negative Gastric MALT Lymphoma. Cancers 15 (4) (2023)
Hiroki Kadota, Ryo Yuge, Daisuke Shimizu, Ryo Miyamoto, Rina Otani, Yuichi Hiyama, Hidehiko Takigawa, Ryohei Hayashi, Yuji Urabe, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
Anti-Programmed Cell Death-1 Antibody and Dasatinib Combination Therapy Exhibits Efficacy in Metastatic Colorectal Cancer Mouse Models. Cancers 14 (24) (2022)
Hiroki Kadota, Ryo Yuge, Daisuke Shimizu, Ryo Miyamoto, Rina Otani, Yuichi Hiyama, Hidehiko Takigawa, Ryohei Hayashi, Yuji Urabe, Yasuhiko Kitadai, Shiro Oka, Shinji Tanaka
Anti-Programmed Cell Death-1 Antibody and Dasatinib Combination Therapy Exhibits Efficacy in Metastatic Colorectal Cancer Mouse Models. Cancers 14 (24) (2022)
Hiroki Kadota, Ryo Yuge, Ryo Miyamoto, Rina Otani, Hidehiko Takigawa, Ryohei Hayashi, Yuji Urabe, Shiro Oka, Kazuhiro Sentani, Naohide Oue, Yasuhiko Kitadai, Shinji Tanaka
Investigation of endoscopic findings in nine cases of Helicobacter suis-infected gastritis complicated by gastric mucosa-associated lymphoid tissue lymphoma. Helicobacter 27 (3) (2022)